A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved ... tenofovir alafenamide and integrase inhibitor bictegravir. ViiV claimed the latter compound infringes its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback